Senate approves $275M to FDA, $400M to NIH

 
FDA and NIH net Senate approval for increased funding. Source: East Carolina University 
The FDA and National Institutes of Health (NIH) received funding increases in the FY 2008 Supplemental Appropriations bill that the Senate passed May 23.

In its $400 million appropriation to NIH, the Senate bill recognizes the need for increased appropriations for the NIH to fund about 700 research grants. The Senate also issued $275 million for the FDA, $437 million for the construction of polytrauma centers administered by the Department of Veterans Affairs and $350 million for hospitals in Louisiana and Mississippi as part of relief from Hurricane Katrina.

Of the $275 million for the FDA, $48 million will go to the Center for Drug Evaluation and Research and $23 million to the Center for Biologics Evaluation and Research. The funding will provide the FDA with the resources to keep pace with evolving biomedical science and make regulatory decisions in a timely and efficient manner, according to the agency.

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.